Effects of biodegradable self-reinforced polyglycolic acid, poly-DL-lactic acid and stainless-steel spiral stents on uroepithelium after Nd:YAG laser irradiation of the canine prostate.
OBJECTIVE
To evaluate the safety and tissue effects on canine uroepithelium and prostate of biodegradable self-reinforced polyglycolic acid (SR-PGA) and self-reinforced poly-DL-lactic acid (SR-PLA) spiral stents compared to stainless-steel (SS) spiral stents.


METHODS
Twenty-five dogs (median body weight 12 kg) underwent a one-stage midline laparotomy and cystotomy. A side-firing Nd:YAG laser fibre was placed in the prostatic urethra antegradely and laser power applied at a setting of 20 W for 10 s in each side lobe, followed by dilatation to 4 mm diameter and insertion of a spiral stent. Dogs were randomized to receive an SR-PGA, SR-PLA or SS stent and no catheter was placed post-operatively. The dogs were killed after a follow-up of 1, 3 or 6 months and the bladder, prostate and urethra removed. Routine histological sections were prepared from the bladder, prostate, the proximal urethra immediately below the prostate and the distal urethra.


RESULTS
Histological examination showed a mild to moderate foreign-body reaction and an acute inflammatory reaction after 1 month in the SR-PGA and the SR-PLA groups. The tissue effect was minimal in the SR-PGA group after 6 and 12 months. The SS stent group had more fibrosis, chronic inflammation and oedema at all follow-up assessments. There were erosions of the epithelium with subepithelial oedema in the animals with the SS stent. No dysplasia was detected and some remnants of the suture material were evident in the area of the cystotomy closure. There was one stricture at the apex of prostate in the SR-PGA group at 3 months in one re-operated dog.


CONCLUSIONS
The histopathological changes in tissues caused by SR-PGA and SR-PLA stents were generally minor and decreased during the follow-up. The biocompatibility of SR-PGA and SR-PLA stents was good when combined with Nd:YAG laser treatment of the prostate.
Pétas
A
A
Department of Urology, Helsinki University Central Hospital, Finland.
Kärkkäinen
P
P
Talja
M
M
Taari
K
K
Laato
M
M
Välimaa
T
T
Törmälä
P
P
D000818:Animals; D001673:Biodegradation, Environmental; D004285:Dogs; D004848:Epithelium; D019344:Lactic Acid / Q000627:therapeutic use*; D007834:Lasers; D008297:Male; D011091:Polyesters; D011100:Polyglycolic Acid / Q000627:therapeutic use*; D011108:Polymers / Q000627:therapeutic use*; D011467:Prostate / Q000528:radiation effects*; D013193:Stainless Steel; D015607:Stents
D011091:Polyesters; D011108:Polymers; D013193:Stainless Steel; D011100:Polyglycolic Acid; D019344:Lactic Acid; C033616:poly(lactide)